Swissmedic Issues Notification for Irbesartan Spirig HC Due to Text Error on Packaging
A recent notification issued by Swissmedic, the Swiss Agency for Therapeutic Products, has brought attention to a critical issue regarding […]
A recent notification issued by Swissmedic, the Swiss Agency for Therapeutic Products, has brought attention to a critical issue regarding […]
Publication date context February 11 2026 at 13 44 UTC. The FDA today launched a comprehensive reassessment of butylated hydroxyanisole
Publication date context February 11 2026. A new randomized controlled trial named RAPHAel is testing robotic technologies to address apathy
Meta description: Completed evaluation of an insulin patch pump system for diabetes management assesses safety and efficacy against Minimed 700,
A new clinical trial evaluates the NOVAtria System for heart failure management, signaling regulatory interest in advanced therapeutic monitoring devices.
This report reviews a real world study of disease modifying therapy in spinal muscular atrophy and outlines regulatory considerations for
This report reviews a new clinical trial comparing tendon grafts and muscle tendon grafts in ACL reconstruction and outlines regulatory
Publication date context: February 11, 2026. This regulatory news brief covers a migraine trial described as middle meningeal artery stimulation
Meta description: This regulatory update reports on a Cairo University trial evaluating a fat cavitation device for lipedema adipose thickness.
Meta description: regulatory update on CHAPERONE AI and CKMiq AI in cardiovascular kidney and metabolic health trials for acute myocardial